Adriana Lisinschi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
ABVD regimen (doxorubicin, bleomycin, vinblastine and dacarbazine) remains the most commonly used front-line therapy for Hodgkin lymphoma. However, atypical and extranodal presentations present challenges to initial therapy, especially in the presence of renal and liver failure. We hereby present two cases of young male patients with atypical presentation(More)
  • 1